Mouly V - Search Results

1

Skeletal muscle characteristics are preserved in hTERT/cdk4 human myogenic cell lines.

Thorley M, Duguez S, Mazza EMC, Valsoni S, Bigot A, Mamchaoui K, Harmon B, Voit T, Mouly V, Duddy W. Thorley M, et al. Among authors: mouly v. Skelet Muscle. 2016 Dec 8;6(1):43. doi: 10.1186/s13395-016-0115-5. Skelet Muscle. 2016. PMID: 27931240 Free PMC article.

2

Telomerase can extend the proliferative capacity of human myoblasts, but does not lead to their immortalization.

Di Donna S, Mamchaoui K, Cooper RN, Seigneurin-Venin S, Tremblay J, Butler-Browne GS, Mouly V. Di Donna S, et al. Among authors: mouly v. Mol Cancer Res. 2003 Jul;1(9):643-53. Mol Cancer Res. 2003. PMID: 12861050

3

IGF-1 induces human myotube hypertrophy by increasing cell recruitment.

Jacquemin V, Furling D, Bigot A, Butler-Browne GS, Mouly V. Jacquemin V, et al. Among authors: mouly v. Exp Cell Res. 2004 Sep 10;299(1):148-58. doi: 10.1016/j.yexcr.2004.05.023. Exp Cell Res. 2004. PMID: 15302582

4

The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy.

Mouly V, Aamiri A, Bigot A, Cooper RN, Di Donna S, Furling D, Gidaro T, Jacquemin V, Mamchaoui K, Negroni E, Périé S, Renault V, Silva-Barbosa SD, Butler-Browne GS. Mouly V, et al. Acta Physiol Scand. 2005 May;184(1):3-15. doi: 10.1111/j.1365-201X.2005.01417.x. Acta Physiol Scand. 2005. PMID: 15847639 Review.

5

Myoblast transfer therapy: is there any light at the end of the tunnel?

Mouly V, Aamiri A, Périé S, Mamchaoui K, Barani A, Bigot A, Bouazza B, François V, Furling D, Jacquemin V, Negroni E, Riederer I, Vignaud A, St Guily JL, Butler-Browne GS. Mouly V, et al. Acta Myol. 2005 Oct;24(2):128-33. Acta Myol. 2005. PMID: 16550930 Review.

6

Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation.

Périé S, Mamchaoui K, Mouly V, Blot S, Bouazza B, Thornell LE, St Guily JL, Butler-Browne G. Périé S, et al. Among authors: mouly v. Neuromuscul Disord. 2006 Nov;16(11):770-81. doi: 10.1016/j.nmd.2006.07.022. Epub 2006 Sep 26. Neuromuscul Disord. 2006. PMID: 17005403

7

Impact on oxidative phosphorylation of immortalization with the telomerase gene.

Auré K, Mamchaoui K, Frachon P, Butler-Browne GS, Lombès A, Mouly V. Auré K, et al. Among authors: mouly v. Neuromuscul Disord. 2007 May;17(5):368-75. doi: 10.1016/j.nmd.2007.01.019. Epub 2007 Mar 23. Neuromuscul Disord. 2007. PMID: 17383182

8

Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies.

Zhu CH, Mouly V, Cooper RN, Mamchaoui K, Bigot A, Shay JW, Di Santo JP, Butler-Browne GS, Wright WE. Zhu CH, et al. Among authors: mouly v. Aging Cell. 2007 Aug;6(4):515-23. doi: 10.1111/j.1474-9726.2007.00306.x. Epub 2007 Jun 8. Aging Cell. 2007. PMID: 17559502 Free article.

9

Replicative aging down-regulates the myogenic regulatory factors in human myoblasts.

Bigot A, Jacquemin V, Debacq-Chainiaux F, Butler-Browne GS, Toussaint O, Furling D, Mouly V. Bigot A, et al. Among authors: mouly v. Biol Cell. 2008 Mar;100(3):189-99. doi: 10.1042/BC20070085. Biol Cell. 2008. PMID: 17988214

10

Heat shock treatment increases engraftment of transplanted human myoblasts into immunodeficient mice.

Riederer I, Negroni E, Bigot A, Bencze M, Di Santo J, Aamiri A, Butler-Browne G, Mouly V. Riederer I, et al. Among authors: mouly v. Transplant Proc. 2008 Mar;40(2):624-30. doi: 10.1016/j.transproceed.2008.01.026. Transplant Proc. 2008. PMID: 18374147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters